2m 2m 2m 2m 2m 2m 2m
CUE BIOPHARMA (CUE)
NASDAQ
$27.40+$0.50 (+1.86%)
Price as of Jun 23, 2026 6:33 PM EDT- $129.1MMarket Cap
- 56.39%1-Year Change
- BiotechnologyIndustry
CUE BIOPHARMA (CUE)
$27.40+$0.50 (+1.86%)
CUE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $26.90 | ||
Change | -$3.83 (-12.46%) | ||
Open | $30.25 | ||
High | $30.56 | ||
Low | $25.80 | ||
Previous Close | $30.73 | ||
Volume | 92,688 | ||
30-Day Average Volume | 88,659 | ||
1-Week Change | 12.60% | ||
1-Month Change | 25.29% | ||
1-Year Change | 23.97% | ||
3-Year Change | -76.59% | ||
5-Year Change | -93.01% | ||
Fundamentals | |||
Shares Outstanding | 4.2M | ||
Total Assets | $30.9M | ||
Market Cap | $129.1M | ||
Enterprise Value | $122.7M | ||
Period: QTR TTM FY | |||
Revenue | $5.7M | ||
Net Income | -$5.2M | ||
Free Cash Flow | -$11.1M | ||
EBIT | -$5.2M | ||
EBITDA | -$4.6M | ||
Net Working Capital | $19.0M | ||
EPS | -$32.40 | ||
Enterprise Value/EBITDA | -27 | ||
Enterprise Value/Revenue | 22 | ||
P/B | 6 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 04/24/2026 | ||
Earnings & Revenue